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Abstract The development of strategies for tissue regen-
eration and bio-artificial organ development is based on
our understanding of embryogenesis. Differentiation pro-
tocols attempt to recapitulate the signaling modalities of
gastrulation and organogenesis, coupled with cell selec-
tion regimens to isolate the cells of choice. This strate-
gy is impeded by the lack of optimal in vitro culture
systems since traditional culture systems do not allow
for the three-dimensional interaction between cells and
the extracellular matrix. While artif icial three-
dimensional scaffolds are available, using the natural
extracellular matrix scaffold is advantageous because it
has a distinct architecture that is difficult to replicate.
The adult extracellular matrix is predicted to mediate
signaling related to tissue repair not embryogenesis but
existing similarities between the two argues that the
extracellular matrix will influence the differentiation of
stem and progenitor cells. Previous studies using undif-
ferentiated embryonic stem cells grown directly on acel-
lular kidney ECM demonstrated that the acellular kidney
supported cell growth but limited differentiation oc-
curred. Using mouse kidney extracellular matrix and
mouse embryonic stem cells we report that the extracel-
lular matrix can support the development of kidney
structures if the stem cells are first differentiated to kid-
ney progenitor cells before being applied to the acellular
organ.
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Introduction
Ground breaking work demonstrated that rat neonatal
kidney cells supported by the extracellular matrix
(ECM) of an adult rat acellular kidney resulted in the
restoration of kidney function [1]. This proof of princi-
ple study set the stage for using acellular kidney ECM
as a substrate for three-dimensional cultures that are a
better representation of the natural kidney environment
compared to two-dimensional cultures. Acellular adult
kidney ECM when combined with kidney cells can
yield information on ECM-cell interactions representa-
tive of tissue repair since in many disease situations
the ECM is exposed and is required to support new
cells that migrate in from the periphery of the damaged
area [2].
Importantly, determining the optimal decellularization
protocol that maintains ECM integrity and determining
the appropriate developmental stage of the therapeutic
cells, whether it be a stem cell or a fully mature renal
cell, are important for delineating the role of acellular
ECM in regenerative medicine studies. Stem and pro-
genitor cells have been tested as potential therapeutic
cells for the treatment of kidney damage [3, 4].
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Studies have also used pluripotent embryonic stem cells
co-cultured with acellular kidneys and determined that
the embryonic stem cells grew well but did not generate
kidney progenitor or mature cells [5]. Another study
using a kidney cell line demonstrated that cells adhere
to the ECM thus proving that the ECM provided struc-
tural support for the cells. Whether the ECM directed
differentiation of the kidney stem cell line towards ma-
ture kidney cell types was not shown as no kidney cell
specific markers were used [6]. In our study we used
acellular adult mouse kidney ECM combined with
mouse stem or progenitor cells differentiated to three
developmental stages; mesoderm, intermediate meso-
derm and metanephric mesenchyme, to determine the
mechanical and biological properties of the adult kidney
ECM in regards to supporting cell differentiation and
survival.
The most effective current therapeutic strategy for
kidney failure is dialysis or transplantation. However,
the average waiting time for a donor kidney is 3–5 years
while the dialysis survival rate over 5 years is only 33%
[7, 8]. In order to develop successful cell therapies we
need a source of therapeutic cells for the treatment of
kidney disease that are easily accessible, easy to grow,
and efficiently differentiated. Developing therapeutic
cells to treat kidney disease or the eventual production
of whole kidneys for transplantation requires our ability
to differentiate pluripotent cells into the different kidney
cell types and induce three-dimensional organization.
Decellularized kidneys can provide both structural and
biological cues that promote progenitor cell differentia-
tion and migration. Advantages to using natural ECM
scaffold over artificial scaffolds include 1) the ECM
scaffold has a distinct three-dimensional architecture that
is difficult to replicate artificially, 2) the ECM scaffold
houses location-specific proteins that guide adhesion,
migration and differentiation, and 3) the vasculature
ECM can be repopulated and utilized for the equal dis-
tribution of media and nutrients. Disadvantages include
being able to procure suitable donor organs for
decellularization. Organs removed during surgical proce-
dures are biopsied for pathology rendering them inap-
propriate for whole organ decellularization. Organs do-
nated for transplantation are in short supply and their
availability is sporadic. We propose that porcine or bo-
vine organs will become suitable alternative. Studies
have determined that there is compatibility between
cells and the ECM of different species [6], but more
studies are required.
Adult ECM, that is supportive of mature cells and
can influence tissue repair and homeostasis (reviewed
in Theocharis. et al. [9],), is an ideal model to test the
potential of pluripotent stem cells to respond to adult
specific signals. Following the recent demonstration of
the ability of the ECM from acellular lung to drive the
differentiation of ES cell-derived endoderm to mature
lung cells led us to investigate if it is possible to
decellularize kidneys while maintaining the same level
of mechanical and biological support we observed with
the lung model [10]. Building on previous published
studies we tested different methods of decellularization
including soak decellularization of thick tissue sections,
as well as perfusion decellularization through either the
vasculature or the ureter of mouse kidneys. We also
tested different detergents and different treatment times.
We are able to demonstrate that the adult mouse kidney
acellular ECM can support the growth and maturation




All mouse work was approved by the Animal Care Committee
at the Toronto Centre for Phenogenomics at Mount Sinai
Hospital, Toronto, Canada.
Kidney Decellularization
Multiple methods were used to decellularized mouse
kidneys. Either whole mouse kidneys or thick transverse
kidney sections- approximately1000μm- cut using a
Leica Vibratome or razor blade, were decellularized un-
der constant perfusion of the decellularization solution.
For whole kidneys, the renal artery was cannulated
using a blunt ended 30-gauge needle and held in place
with 6–0 sutures. The kidney-needle complex was then
attached to surgical tubing with an internal diameter of
3/32″ using a luer lock. The ureter was cannulated
using surgical tubing and held in place with sutures.
The cannu l a s wer e ma in t a ined and used fo r
recellularization. A peristaltic pump was used to achieve
a controlled continuous flow of liquids through the kid-
ney. 0.1% SDS at flow rates of 0.2 and 0.4 ml/min for
12, 24, 48 or 72 h, followed by +/− 1 h wash with
0.1% Triton X-100 then a 24 h wash with 0.1%
PenStrep/PBS. The whole acellular kidney could be sec-
tioned at this point for cell co-culture studies.
Alternatively, kidney sections could be cut first then
decellularized. Thick sections were cut and treated with
0.1% SDS using peristaltic pump (0.4 ml/min) to pro-
vide for a constant flow of the SDS solution over the
sections for 24 h, followed by wash in PBS (O/N) and
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PBS/PenStrep for 1 h. The constant flow resulted in the
removal of cellular debris.
Two alternative detergents were tested: 0.1% Triton X100
for 24–72 h or 0.4% Sodium Deoxycholine for 24–72 h +/−
90 U/ml benzonase for 2 h, were used to decellularize the
kidney at the same flow rate and times as for the SDS protocol.
If required, decellularized kidneys were stored at 4 °C for
<5 days prior to recellularization.
Kidney Recellularization
A 30-gauge needle was used to overlay and inject cells
into acellular kidney sections. The repopulated kidney
sections were cultured submerged in 10%FBS/DMEM/
Antibiotic. For whole kidney recellularization the cells
were introduced through the ureter while the kidney was
under negative pressure. The negative pressure was ap-
plied using a vacuum hooked up to a chamber made
from either a 50 ml plastic tube or a glass bottle. The
vacuum was maintained just for cell loading. Whole
kidneys were fed by perfusing 3–5 ml of medium
through the vasculature daily or continuous perfusion
with medium. Sections were maintained with 50% me-
dium changes daily. All recellularized kidneys were in-
cubated at 37 °C, 5% CO2.
Tissue Processing and Immunochemistry, Hematoxylin
and Eosin (H&E) Staining
All tissues were fixed in 10% neutral buffered formalin (NBF)
and processed as described [11].
Primary antibodies: All used at 1:100: β-Catenin (Santa
Cruz sc7199), Brachyury (BRY) N-19 (Santa Cruz sc-
17,743), HNF3β respectively (Millipore 07–633 and Santa
Cruz SC9187), OCT-3/4 (Santa Cruz sc-8628), PAX-2
(Covance PRB-276P), SIX-2 (ProteinTech, 11,562-AP),
SOX-17 (R&D Systems AF1924), WT-1 (Abcam ab89901).
Keratin-16 (KSP) (Novus Biologics NB159248), Laminin
(Abcam ab11575), Fibronectin (Abcam ab23750), Collagen
IV (Abcam ab6586), HSPG (Abcam ab2501), Vimentin
(San ta Cruz sc7558) , Podoc in (S igma P0372) ,
panCytokeratin (Sigma p2871).
Cells were stained with DAPI to detect nuclei and the sig-
nal was preserved using DABCO. Images were analyzed on
the Leica DM IL microscope and images were taken with a
Hamamatsu ORCA-03G camera.
Quantification of Cells Three fields of view were randomly
chosen/well. All DAPI stained cells and desired antibody pos-
itive stained cells were counted per field.
Isolation of Day 12.5 Renal Progenitor Cells
Day 12.5 embryos were retrieved from pregnant dams and all
extraembryonic tissues were removed. The head was removed
and the liver, lungs and digestive systemwere gently removed
revealing the developing kidneys. Kidneys were collected and
washed in cold PBS, followed by gentle trituration to obtain a
single cell population.
ES Cell Culture
B6 e-GFP and BRY-GFPmouse ES cell lines [12] were grown
on mitomycin C mitotically inactive mouse embryonic fibro-
blast (MEF) feeder layers. Cells were passaged every other
day using 0.25% trypsin (Life Technologies) and split at a
ratio between 1:10 and 1:20. Cells were incubated at 37 °C,
5% CO2.Mouse ES cells were cultured in standard mouse ES
medium supplemented with LIF (1000 U/mL, Life
Technologies). Mouse ES medium was made with 500 mL
DMEM (GIBCO), 20% FBS (GIBCO), 0.5× PenStrep
(GIBCO), 100 μM β-mercaptoethanol (Sigma), 1 mM Na
pyruvate (Sigma), 10 μM non-essential amino acids
(GIBCO), 2 mM GlutaMAX™ (Invitrogen).
Differentiation Protocol
Mouse ES cells from a 90% confluent plate were used
for differentiation. Cells were washed with PBS and
trypsiznized with 0.25% trypsin and incubated at
37 °C for 5 min to allow cells to detach from feeders
and plate. Cells were centrifuged at 1200 rpm for 4 min
at 10 °C and supernatant was removed and cells were
resuspended in mesoderm differentiation medium:
Variations of the medium used are described in detail
in the results section:
Final Protocol
Stage 1: Mesoderm: 200,000 cells/cm2 on gelatin plates
two days wi th Serum Free Medium (SFM):
DMEM/F12 + 0.5% serum replacement, Activin A
30 ng/mL to induce mesoderm.
Stage 2: Intermediate mesoderm: Two days in serum con-
taining medium (SCM): DMEM/high glucose, 4% FBS,
10 μM Y-27632 and 30 ng/ml Activin A, 100 nm RA to
induce PAX2+ intermediate mesoderm.
Stage 3: Mesenephric mesenchyme: Followed by
3.5 days in Modified SCM (4% serum in DMEM)
supplemented with FGF2 at 0.1 ng/ml to induce
Six2+ cells. Change medium at day 1.5. Wash 1×
PBS between media changes.
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Components
Name of product Company Catalogue
number
2-Mercaptoethanol Sigma-Aldrich M7522
Accutase™ Innovative Cell Technologies AT-104





BMP-4 Invitrogen Life Technologies PHC9534





DMEM/High Glucose In house NA
Fetal Bovine Serum In house
FGF2 Invitrogen 13256–029
GDNF R&D Systems 212-GD-010








Serum replacement Invitrogen 10828–028
Stauprimide Tocris Biosciences (R&D
Systems)
154589–96-5





RNAwas isolated using Qiagen RNA Isolation Kit and cDNA
was made. Primers sequences were as follows:
Pax-2 (5’-AGGGCATCTGCGATAATGAC-3’ and 5’-
CTCGCGTTTCCTCTTCTCAC-3’)
Wt-1 (5’-ACCCAGGCTGCAATAAGAGA-3’ and 5’-
GCTGAAGGGCTTTTCACTTG-3’)
PCR was performed with a denaturation at 94 °C for
2.5 min and 30 cycles for 94 °C for 30 s, annealing at 58 °C
for 1 min, 72 °C for 1 min and 72 °C for 10 min for final
extension.
Emx2 (5’-CCGAGAGTTTCCTTTTGCA-3’ and 5’-
GCCTGCTTGGTAGCAATTC-3’)
Eomes (5’-GGCAAAGCGGACAATAACAT-3’ and 5’-
AGCCTCGGTTGGTATTTGTG-3’)




Sall1 (5′-CCCCATCCCTATTAGCCATT-3’ and 5’-
AGAGTACTGTTGCCCGCTGT-3’).
Annealing at 56 °C for 1 min
Mesp1 (5’-CCTTCGGAGGGAGTAGATCC-3’ and 5’-
AAAGCTTGTGCCTGCTTCAT-3’).
Annealing at 54 °C for 1 min
ß-Actin(5’-CATCCGTAAAGACCTCTATGC-3’and5’-
AGAAAGGGTGTAAAACGCAGC-3’)
Gsc (5’-AACGCCGAGAAGTGGAACAA-3’ and 5’-
AGGCAGGGTGTGTGCAAGT-3’)
Cited1 (5’-ATGCCAACCAGGAGATGAAC-3’ and 5’-
AAGCTCATTGGCTCGGTCTA-3’)
Annealing at 60 °C for 1 min.
Cytokine Array
Mouse proteome array kit from R and D systems
(ARY015 ) was u s ed t o de t e c t cy t ok i n e s on
decellularized extracellular matrices. User manual was
followed to conduct protocol. Arrays were exposed to
X-ray film for 1, 2, 3, 5, 10 and 15 min. Pixel density
was measured with the ImageQuant program and charts
were made using Microsoft Excel. Protein networks
were determined using STRING v.10 (Search Tool for
the Retrieval of Interacting Genes/Proteins). Three inde-
pendent experiments were done and each one was done
in triplicate to obtain the mean pixel density.
Scanning Electron Microscopy
For SEM samples were fixed in 2.5% glutaraldehyde in
0.1 M phosphate buffer pH 7.4 and post-fixed in osmi-
um tetroxide, dehydrated in an ascending series of eth-
anols and critical point dried. All samples were then
mounted on aluminum stubs using double-sided carbon
tape and rendered conductive with a thin coat of gold
palladium using a sputter coater and examined and
photographed in a field emission scanning EM using a
Phi l l ips FEI XL30 (30 kV Scanning Elect ron
Microscope).
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Results
Preparation and Characterization of biologically Active
Extracellular Matrix
To maximize the biological activity of the ECM, it was
critical to determine the minimal decellularization treat-
ment that is required to remove cells but retain the
ECM architecture and embedded growth factors that
would support cell survival, adhesion and differentiation
[16, 17]. Whole mouse kidneys or transverse kidney sec-
tions were decellularized in a solution of 0.1% SDS or
1% Triton X-100 or 0.4% Sodium deoxycholate by con-
tinuous perfusion. Intact mouse kidneys were perfused
using whole organ retrograde perfusion through cannula-
tion of the renal artery. We also attempted perfusion
decellularization through the ureter. The artery cannulation
allowed for the continuous flow of decellularization solu-
tion through the kidney without causing a build up of
pressure when flow rates of 0.2–0.4 ml min−1 were used.
Triton X-100, a non-ionic detergent had been demonstrat-
ed to maintain ECM proteins better than SDS, but it was
not an effective decellularization agent for dense organs
such as cardiac tissue and kidney [13]. In our hands
Triton X-100 did not result in decellularization. Even after
48 h of continuous perfusion there was no indication that
any decellularization was occurring. Sodium deoxycholate
was able to lyse cells but much of the cellular debris
remained in the kidney even with constant perfusion.
Treatment with benzonase did not improve the clearance
of the cell debris and DNA (Supplementary Fig. 1). Thus,
SDS was the only treatment that resulted in removal of
cellular proteins and DNA. We also attempted to
deceullarize using a cannulated ureter instead of the vas-
culature. Perfusion through the ureter using 0.1% SDS at
0.4 ml min−1 did not result in any noticeable
decellularization even after 48 h of continuous perfusion,
indicating that the blind ends of the bowman’s capsule
results in back pressure that prevented proper
decellularization.
Using the whole organ retrograde perfusion with 0.1%
SDS, most whole kidneys were fully decellularized at 24–
48 h but in some cases residual cellular debris including
DNA remained. Decellularization for 72 h followed by 24 h
of PBS perfusion was optimal for achieving fully
decellularized kidney (Fig. 1 a, b). H&E staining post
decellularization revealed that kidney microstructures main-
tained intact (Fig. 1c, d) and corrosion casting and dye infu-
sion revealed that the vasculature, including capillaries, was
not damaged (Fig. 1e, f). Interestingly, the liquids perfused
through the acellular vasculature did not leak through the
ECM as expected. This has also been observed by others
and is likely due to the release of tension on the ECM structure
due to the loss of cells, causing the ECM protein strands to
contract thus forming a barrier [14].
Scanning electron microscopy (SEM) and immunofluores-
cence (IF) were utilized to observe the details of the acellular
kidney ultrastructure (Fig. 2a,b). Intact tubules, blood vessels
and glomeruli could all be observed. Breaks in the capillary
tufts were at the plane of sectioning and the extremely thin
capillaries were not damaged by the flow of decellularized
solutions (Fig. 2Aiv-arrow). A large blood vessel still
contained fine elastin fibers after decellularization further
attesting to the retention of fine ECM structures after
decellularization (Fig. 2Av-arrow,vi).
Sections of decellularized kidney were stained with H&E
to confirm complete decellularization. Then adjacent sections
were analyzed by IF and are displayed at three different mag-
nifications to show the broad staining pattern and the region
specificity (Fig. 2b). Laminin and Fibronectin demonstrated
ubiquitous staining, while Collagen IV and Heparan Sulfate
Proteoglycan (HSPG) were uneven with more protein ob-
served in the glomeruli. HSPG is a basement membrane pro-
tein that sequesters and regulates FGF, BMP and WNT, and
promotes interactions between cells and the ECM.
Fibronectin, Laminin and Collagen IV are ECM proteins in-
volved in cell adhesion and cell migration [15, 16]. The non-
uniformity of the HSPG and Collagen IVexpression could be
due to the action of the SDS decellularization reagent or kid-
ney specific localization. IHC with the fluorescent secondary
antibody only, along side the primary antibody plus secondary
antibody staining, bright-field pictures and DAPI of normal
mouse kidneys and decellularized mouse kidneys are in
Supplementary Fig. 2. Complete decellularization is demon-
strated by the complete absence of DNA (DAPI stain nega-
tive). ECM proteins, Laminin, Fibronectin and Collagen IV
are present in both untreated and decellularized mouse kid-
neys. Secondary antibody only staining demonstrates the re-
sults is due to specific staining of the primary antibody.
Decellularized Kidneys Are Not Immunogenic
Although the acellular kidney can be used as a 3D substrate
for tissue culture to test properties of individual kidney cells,
ultimately the goal is to use acellular organs and stem cells to
produce a whole functional organ for transplantation.
Potential sources for acellular kidney substrates include hu-
man donor kidneys that are not suitable for transplantation due
to HLA mismatching, damage or disease. An alternative
source is bovine or porcine kidneys. For any source to be
practical for use in transplantation, the acellular kidney must
not be immunogenic. We tested this by decellularizing a
C57Bl/6 mouse kidney (H2Kb) using our SDS perfusion sys-
tem and then transplanted a whole acellular kidney into the
abdomen of CD1 (H2Kd) mice by attaching the kidney to the
fat pad. After two weeks the fat pad and kidney were excised.
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No morphological damage was observed indicating that
mouse ECM proteins are not antigenic and acellular organ-
stem cell constructs can be used to produce organs for trans-
plantation (Fig. 2c arrows indicate kidney-fat pad border).
Protein Array Analysis of the Acellular Kidney
The goal of decellularization was to retain ECM proteins post
decellularization including focal adhesions containing
cytokeratins and integrins. We hypothesized that the retention
of bioactive proteins, such as HSPG, would aid in the repop-
ulation and differentiation of stem and progenitor cells as ob-
served in studies of acellular lungs repopulated with ES cell-
derived endoderm [10]. To further assess the proteins that
were present in the decellularized ECM, a protein array of
53 proteins was employed. It was determined that the ECM
possessed 22 of the 53 proteins tested. The role of the 22
proteins is summarized in Table 1.
In order to assess possible interactions between the
22 highly expressed proteins we used STRING (Search
Tool for the Retrieval of Interacting Genes/Proteins)
[17] (Fig. 3). STRING identified a number of functional
enrichments. Many of the biological process identified
were involved in cell migration including cell locomo-
tion and localization. Molecular functions that were
identified were related to biological processes and in-
cluded receptor binding, cytokine and chemokine activ-
ities. Cellular component pathways identified, not sur-
prisingly, were grouped together under extracellular ma-
trix components. KEGG (Kyoto Encyclopedia of Genes
and Genomes) pathways identified both focal adhesion
and cytokine-cytokine receptor signaling pathways.
Taken together, the different processes identified were
Fig. 1 Adult mouse kidneys
were decellularized with 0.1%
SDS for 72 h at a flow rate of
0.4 ml/min. The kidney capsule
interferes with soaking methods
so a continuous flow system was
used for whole organ
decellularization. Ai) Solutions
are pumped through the
vasculature of the cannulated
kidney using a peristaltic pump.
Aii) The kidney is kept at the air-
liquid interface during de-
cellularization. This helps to
move cellular debris away from
the kidney. B) De-cellularization
progression of an adult mouse
kidney. i) time = 0 h, ii)
time = 24 h and iii) time = 72 h.
(C) H&E staining showing intact
glomeruli (G) and Bowman’s
capsules (BC) at 20× and (D)
40×. (E) Progressive vascular
corrosion casting of a mouse
kidney show multiple intact
glomeruli (arrow) and (F) intact
vasculature. Magnification
bar = 100 μm
Stem Cell Rev and Rep
related to tissue regeneration and repair. Induction of
embryo development processes did not reach signifi-
cance suggesting the decellularized kidney ECM has a
stronger role in tissue regeneration than organogenesis.
This may also be a function of GO term definitions as
‘embryo developmental’ processes include the whole
embryo and not just kidney organogenesis.
Repopulating Acellular Kidneys
Acellular kidney sections or whole kidneys were combined
with cells to determine cell distribution and survival. Thick
sections of acellular kidney were either injected with cells or
overlaid with cells. Both protocols resulted in large areas of
the ECM being repopulated. The route for repopulating the
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whole decellularized kidney required some consideration.
Although cells were capable of moving through the ECM
under normal organ activity [18], there was little evidence that
this occurred with high efficiency with decellularized organs.
Therefore, introducing nephron-specific cells through the ure-
ter was required, instead of using the vasculature and
expecting the cells to migrate across the ECM. The renal ar-
tery was cannulated with a needle while the ureter was can-
nulated with a flexible tube. Repopulation of the whole kidney
through the ureter was done by placing the kidney in a vacuum
chamber that set up a negative pressure gradient in the kidney
resulting in the even distribution of cells into the cortical re-
gion. Renal epithelial cells or stromal cells were used to test
repopulat ion of a whole acellular mouse kidney
(Supplementary Fig. 3). Although cell repopulation of whole
acellular kidneys worked well, acellular kidney sections were
easier to use and allowed for the analysis of multiple param-
eters using less kidney tissue and fewer animals. Sections
were used throughout this study.
Adult Acellular Kidney ECM Has a Limited Impact
on the Differentiation of ES Cells and Intermediate
Mesoderm
The kidney is composed of over thirty different cell types.
Attempting to generate each of the required mature cells
in vitro, followed by placing them at the correct coordinates
within the acellular kidney would be impossible. We hypoth-
esized that the ECM of the acellular kidney maintains local-
ized bioactive proteins that may guide the differentiation of
stem or progenitor cells, cell migration, homing and cell
adherence. In order to test the differentiation induction capac-
ity of the ECM,we generated and used undifferentiated mouse
ES cells, ES cell-derived BRY+ mesoderm, PAX2+ interme-
diate mesoderm (IM) and SIX2+ metanephric mesenchyme
(MM) stage cells that were co-cultured with decellularized
kidney ECM or on gelatin coated plates as negative controls.
Monolayers of ES cells grown without LIF for four days on
gelatin plates acted as controls for spontaneous differentiation.
Undifferentiated mouse ES cells survived and proliferated
on both gelatin plates (control) and the acellular kidney. ES
cell grown on gelatin-coated plates (minus LIF) underwent
spontaneous differentiation as expected, producing SOX17+
and HNF3ß + endoderm and BRY+ mesoderm (Fig. 4a-c).
Two kidney proteins, Cytokeratin and ß-Catenin, were also
produced from the spontaneously differentiating cells
(Fig. 4d, e). Oct4 pluripotent cells were still present mainly
in areas of cell colonies (Fig. 4f). In contrast, ES cells grown
on the decellularized adult kidney sections (minus LIF) were
positive for only mesoderm as they expressed ß-Catenin and
PAX2 (Fig. 4g,h). The cells did not differentiate into endo-
derm as the cells were negative for SOX 17 (Figure Ii).
Despite the ability to make mesoderm, more mature kidney
cells did not form nor did mature structures such as tubules
since the cells were negative for KSP (Figure 4Iii-iii). This
observation suggested that the kidney ECMmay retain bioac-
tive proteins that preferentially supported the differentiation of
ES cells to mesoderm over endoderm but not to mature kidney
cells. Lastly, we heat-treated the ECM at 55 °C for 10 min and
applied ES cells. There were few cells observed and all were
negative for mesoderm, IM and kidney proteins indicating the
ECM provides some bioactive support for differentiation to
mesoderm that is heat sensitive (data not shown).
The ability of the ECM to support ES cell differentia-
tion to mesoderm but not endoderm or mature kidney
cells prompted us to investigate what would occur if me-
soderm, PAX2+ IM or SIX2+ MM cells were co-cultured
with the ECM instead of pluripotent ES cells. Despite
being able to generate mesoderm the kidney ECM could
not support further differentiation but it was possible that
the adult ECM was more supportive of later stage differ-
entiated cells, as dedifferentiation and re-differentiation is a
hallmark of kidney repair [19]. In order to determine the
extent that the kidney ECM can support further kidney
differentiation or cell proliferation and growth of different
stages of kidney development we applied mesoderm,
PAX2+ IM or SIX2+ MM cells to acellular kidney sec-
tions. A protocol to generate mouse ES cell-derived me-
soderm, IM and MM cells using cell monolayers in de-
fined differentiation media was developed. Since differen-
tiation efficiency varies with different ES cell lines and
protocols, the optimal concentrations of growth factors,
serum and inhibitors for mouse B6 eGFP and BRY-GFP
ES cell differentiation was determined empirically.
Fig. 2 Characterization of decellularized adult kidney matrices.
Scanning electron microscopy of a decellularized kidney. (Ai,ii) Low
and high magnification of the kidney cortex depicts the large array of
nephron tubules. High magnification of intact decellularized tubules
demonstrated that all cells and cellular debris were removed while
keeping the ECM intact. (Aiii, iv) Cross sections of glomeruli and
Bowman’s capsules can be observed. At the plane of the tissue cross
section the glomerular basement membrane can be seen (arrow).
Despite the thinness, the glomerular basement membrane remained
intact. (Av, vi) A cross section of a renal artery (arrow) and high
magnification of the internal structure of the same renal artery showing
the elastin fiber structure remained intact. (B) H&E staining shows no
cells remain on the ECM, and the architecture of the kidney matrix
remains intact (lower right). Laminin and Fibronectin were expressed
ubiquitously in the decellularized kidney matrix indicating that the
structural and biological integrity of a decellularized matrix is intact.
Collagen IV and HSPG demonstrate regions of high and low protein
expression with the strongest expression in the glomerular ECM. This
is best illustrated at the higher magnification. (C) To test antigenic
potential of the ECM an adult C57Bl/6 mouse kidney was decellularized
for 24 h and transplanted into a CD1 mouse by folding the abdominal fat
around the kidney and autopsied after 14 days. Note the minimal cell
infiltration and the decellularized kidney morphology remained
unchanged. The border between the acellular kidney and the fat pad is
denoted by arrows
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Table 1 Analysis of ECM proteins by protein array. The decellularized adult mouse kidney ECM contains proteins required for cell differentiation,
survival and ECM remodeling. Protein array of acellular adult kidneys demonstrated the expression of 22 proteins. Their roles and interactions are listed
Pathway ID Biological Process (GO) Genes Adj. P value
GO:0040012 regulaon of 
locomoon
15
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, CCL2, MMP3, MMP9, 
PDGFRA, PTX3, PDGFRB, 
CXCL12, SerpinE1, SerpinF2, 
TIMP1
4.3e-15
GO:0030334 regulaon of cell 
migraon
14
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, CCL2, MMP3, MMP9, 




GO:0030335 posive regulaon of 
cell migraon
11
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, CCL2, MMP9, 
PDGFRA, PDGFRB, CXCL12, 
Serpine1
3.3e-12
GO:0032879 regulaon of 
localizaon
16
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, IL-10, CCL2, MMP3, 
MMP9, PDGFRA, PTX3, 
PDGFRB, CXCL12, SerpinE1, 
SerpinF1, TIMP1
4.45e-10
GO:0048522 posive regulaon of 
cellular process
19
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, IBP-1, IBP-2, IL-10, 
CCL2, MMP3, MMP9, 
2.19e-09
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Table 1 (cotinued)
Osteopontin, PDGFRA, PTX3, 
PDGFRB, CXCL12, SerpinE1, 
Thrombospondin-2, TIMP1
Pathway ID Molecular Funcon (GO) Genes Adj. P value
GO:0005102 receptor binding 11
CXC16, CYR61, IL-10, CCL2, 
NOV, Osteopontin, PDGFRA, 
PDGFRB, CXCL12, Serpine1, 
TIMP1
1.02e-06
GO:0005515 protein binding 18
CXC16, PAR-2, Collagen 
alpha-1(XVIII) chain, CYR61, 
HGFR, IBP-1, IBP-2, IL-10, 
CCL2, MMP9, NOV, 
Osteopontin, PDGFRA, PTX3, 
PDGFRB, CXCL12, SerpinE1, 
TIMP1
1.02e-06
GO:0005125 cytokine acvity 6
CXC16, IL-10, CCL2, 
Osteopontin, CXCL12, TIMP1
1.92e-06






GO:0008009 chemokine acvity 3 
CXC16, CCL2, CXCL12, 
0.000937
Pathway ID Cellular Component (GO) Genes Adj. P value
GO:0005615 extracellular space 12
CXC16, IBP-1, IBP-2, IL-10, 
CCL2, MMP9, Osteopontin, 
PTX3, CXCL12, SerpinE1, 
SerpinF1, TIMP1
3.43e-09
GO:0031012 extracellular matrix 9
Collagen alpha-1(XVIII) chain, 




GO:0044421 extracellular region part 17
CXC16, Collagen alpha-1(XVIII) 
chain, CYR61, HGFR, IBP-1, IBP-
2, IL-10, CCL2, MMP3, MMP9, 
NOV, Osteopontin, PTX3, 
PDGFRB, CXCL12, SerpinE1, 
Thrombospondin-2, TIMP1
2.55e-08
GO:0005578 proteinaceous extracellular 
matrix
8
Collagen alpha-1(XVIII) chain, 




GO:0005576 extracellular region 17
CXC16, Collagen alpha-1(XVIII) 
1.67e-07
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FGF2, Activin A and BMP4 have critical roles in meso-
derm induction during gastrulation. Hence, different combi-
nations and concentrations of these three factors were used on
monolayers of ES cells in Serum Free Medium (SFM). The
following conditions were tested: DMEM/F12 + 0.5% serum
replacement media containing Activin A (5, 30 or 50 ng/ml)
+/− FGF2 (0.01–50 ng/ml) and +/− BMP4 (5–50 ng/ml).
Activin A alone at all three concentrations resulted in BRY+
cells. The addition of high concentrations of FGF2 resulted in
high levels of cell proliferation, the retention of ES-like colo-
nies and low BRYexpression (<1%). FGF2 at 0.01 and 0.1 ng/
ml with all concentrations of Activin A showed no improve-
ment over Activin A alone. The addition of BMP4 to all of the
growth factor combinations had a mild antagonistic role in our
system consistent with studies indicating a central role of
SMADs in balancing BMP4 and Activin A signaling during
mesoderm patterning [20]. Activin A alone at 30 ng/ml was
sufficient to differentiate >80% of the ES cells to Bry + cells
(Fig. 4Ji-ii). We hypothesize that in monolayer cultures the
normal cell-cell interactions that occur during embryo devel-
opment are absent and this accounted for the reduced role for
FGF2 and BMP4 in monolayer differentiation cultures. The
Bry + cells also expressed markers of mesendoderm and me-
soderm, namely Gsc, Eomes and CD56. Mesp1 was negative
indicating that the mesodermwas not yet specified into lateral,
intermediate or paraxial mesoderm (Fig. 4Jiii). In order to test
the potential of the kidney ECM to differentiate BRY+ cells to
mature kidney cells, the BRY+ cells were harvested from the
plates and layered onto acellular kidney ECM as described for
ES cells. The majority of cells did not survive disassociation
and replating despite the use of various disassociation agents
and ROCK inhibitor and the few surviving cells did not attach
to the ECM.
We next determined if PAX2+ IM would survive the dis-
sociation and repopulating process better than early stage me-
soderm. Retinoic acid (RA) has an important role in patterning
the developing embryonic tissue into lateral, intermediate and
paraxial mesoderm [21–23]. Activin A also continues to be
important for intermediate mesoderm patterning during em-
bryogenesis [24] and BMPs establish a concentration gradient
that patterns the dorso-ventral axis. We tested different con-
centrations of these growth factors in order to induce PAX2.
Concentrations of Activin A (5 ng/ml to 50 ng/m) with or
without BMP4 (50 ng/ml), BMP7 (50 ng/ml) and RA
(100 nM) in SCM were tested. Initial plating confluency and
plate coating were also taken into consideration.
Serum or serum replacement was tested at concentrations
ranging from 0.5% to 10% with or without ROCK inhibitor, a
potent inhibitor of apoptosis, in order to optimize cell survival
and differentiation rates [25]. Cell loss during differentiation
meant maximizing the initial cell density but not at the risk of
disrupting the cell monolayer, which was vital to uniformly
differentiated cells. Protocols using embryoid bodies rely on
cell-cell signaling to induce and maintain differentiation while
using monolayers of cells as done here, requires the determi-
nation of the appropriate cell density that induces differentia-
tion but does not overcrowd the cells as they keep proliferat-
ing. Cells were plated at a density of 50 K, 10 K or 2.5 K per
cm2 on gelatin plates at the start of the differentiation protocol.
Low cell density resulted in few PAX2+ cells (<5%)
(Fig. 4Ki-ii). Although the majority of cells survived they
did not differentiate indicating that cell-cell signaling is im-
portant for the differentiation process and thus higher cell
densities are required. Starting with 50 K cells/cm2 for stage
1 (mesoderm) resulted in a dense monolayer of BRY+ cells
that yielded PAX2+ cells at subsequent differentiation stages.
The final conditions that yielded the highest frequency of
PAX2+ cells (80%+) was 50 K cells/cm2 on gelatin plates
for 2 days with Activin A 30 ng/mL to induce mesoderm
followed by 2 days in PAX2 induction conditions comprised
of DMEM/high glucose, 4% FBS, 10 μMY-27632 and 30 ng/
ml Activin A, 100 nm RA (Fig. 4Kiii-iv).
Table 1 (cotinued)
chain, CYR61, IBP-1, IBP-2, IL-
10, CCL2, MMP3, MMP9, NOV, 
Osteopontin, PTX3, PDGFRB, 
CXCL12, Serpine1, 
Thrombospondin-2, TIMP1
Pathway ID KEGG (GO) Genes Adj. P value





GO: 0004510 Focal adhesion 9
HGFR,Pdgfra,Pdgfrb,Osteopontin,Thbs2
0.000127
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The transfer of PAX2+ cells to the acellular kidney gave the
same results as the BRY+ cells. The PAX2+ IM cell survival
was low after disassociation even when ROCK inhibitor was
added suggesting that at the IM stage cell-cell contact is im-
portant for cell survival. As an alternative strategy, ES cells
were directly plated on acellular kidney sections and grown in
conditions described above to generate PAX2+ cells. All cells
died before PAX2 induction occurred. We speculate that the
presence of exogenous growth factors combined with bioac-
tive proteins on the ECM were not conducive to differentia-
tion and survival of ES cells.
ES Cell Derived Metanephric Mesenchyme Cells Grown
on Decellularized Kidney Matrices Can Differentiate
to Kidney Cells and Develop Tubule Morphology
During kidney development the IM give rise to the nephric
duct (ND) which eventually gives rise to the Ureteric Bud
(UB), and the MM. The interaction between MM (precursor
for the nephron) and the UB (precursor for the Collecting duct
and Renal Pelvis) results in the formation of a functional kid-
ney. At this stage of development a single cell suspension
isolated from E12.5 mouse kidneys can be cultured in vitro
and can undergo differentiation and branching morphogenesis
[26, 27]. We hypothesized that if we could induce ES cell
derived IM to further differentiate to the equivalent stage of
a mouse E12.5 kidney then the cells might survive disassoci-
ation and be good candidates to repopulate the acellular kid-
ney. In order to produce E12.5 equivalent kidney cells, mono-
layers of ES cell derived IM (PAX2+) cells were cultured in
modified serum containing medium (SCM) (4% serum in
DMEM) supplemented with FGF2 at 0.1–100 ng/ml, +/−
BMP-7 at 5–50 ng/ml for 3.5 days. We screened cultures for
SIX2+ cells, a marker of MM. While we did achieve some
SIX2+ induction with all conditions, the condition with
BMP7 (5 ng/ml) and FGF2 (0.1 ng/ml) (M1 medium) or
FGF2 alone (0.1 ng/ml) (M2 medium) gave the highest cell
survival and the highest yield with 30% of the cells being
SIX2+ (Fig. 4Li-ii). Increasing the BMP7 to 25 ng/ml resulted
in less SIX2+ cells (Fig. 4Liii). PCR confirmed the induction
of MM. ß-Actin was used to normalize between experiments.
MM positive gene expression included Pax2, Wt1, Cited 1,
Emx2, Sall1 and Hoxd11. Because our data indicated that
BMP7 is not essential, all further studies were carried out with
M2 medium (Fig. 4m). The cultures also contained
Cytokeratin + cells indicating that some UB-like cells were
present and some cells did not differentiate as they were neg-
ative for both SIX2 and Cytokeratin. In order to increase the
absolute number of MM cells, we tested using higher plating
densities at the mesoderm induction stage. Using 200,000
cells/cm2 improved the yield of MM cells overall despite this
being sub-optimal for PAX2 induction. Overall, the final pro-
tocol to obtain MM cells was a compromise with optimal
BRY+ cell yields and PAX2+ cell yields. It is possible that
since the cells are not synchronized some cells that are lagging
during differentiation get caught up in the last culture stage.
The MM cells could be harvested from the plates using
accutase and successfully grown on acellular kidney sections
using 10% FBS in DMEM (Fig. 5).
E12.5 kidney cells were used to determine the survivability
of renal progenitor cells grown on acellular kidney ECM.
Cell-ECM complexes were grown for 10 days in 10%FBS/
DMEM and resulted in good cell survival indicating the cul-
ture conditions would support renal progenitor cells
(Fig. 5Ai). For ES cell-derived MM cells the repopulation
frequency varied between experiments, but 10–50% repopu-
lation of the acellular kidney was common. Repopulated cells
could be found evenly spaced throughout the acellular ECM.
The cell-acellular kidney co-cultures were stained with DAPI
and Vimentin to highlight cell distribution within the ECM
(Figure 5Aii). Staining for Collagen IV revealed that the cells
were able to remodel the acellular ECM as the Collagen IV
content was higher in the recellularized area. The ability of the
cells to remodel the ECM helped to improve the cellular en-
vironment and contributed to increased cell survival. Cells
also produced highly organized tertiary structures that
conformed to the existing tubule ECM (Fig. 5b, compare
repopulated area –upper region to unpopulated area-lower re-
gion). This observation suggested the cells attached to the
existing ECM of the acellular kidney resulting in the relining
of the tubule ECM with the new cells. Furthermore, highly
organized structures were never observed with non-
differentiated ES cells co-cultured with acellular kidneys.
MM cell-acellular kidney constructs were stained with non-
kidney markers including PDX1, Tubulin III, HNF3β and
SOX17 to determine the rate of spontaneous differentiation.
All results were negative confirming that no spontaneous dif-
ferentiation occurred (Data not shown).
During kidney development PAX2 appears during interme-
diate mesoderm formation, followed by a reduction in the
uncondensed mesenchyme but is re-expressed in the nuclei
of cells in condensed mesenchyme [28]. We observed
PAX2+ nuclei in cells found in the cortex region of the
repopulated kidney indicative of the formation of condensing
mesenchyme (Fig. 5Ci,ii). In normal kidney development ß-
Catenin demarcates the differentiation of metanephric mesen-
chyme to pretubular stage kidneys. Our observation of ß-
Catenin positive cells was in line with the acellular kidney
supporting the growth and continued differentiation of ES cell
derived MM cells (Fig. 5d) [29]. Cytokeratin staining of a
normal mouse kidney (Fig. 5e) was comparable to the
Cytokeratin staining demonstrated by the ES cell derived-
MM cells that were used to repopulate the acellular kidney.
Well-defined tubules are found throughout the repopulated
ECM (Fig. 5Fi-iv and insets). KSP is a marker for tubule cells
and repopulated areas were observed to have strong KSP
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staining (Fig. 5g) and had a similar staining pattern as the
control kidney (Fig. 5h). WT-1 is important for metanephric
mesenchyme maintenance but is also important for proper
glomerular development and is expressed in podocytes [30].
WT-1 nuclear protein was observed in cells found in the glo-
merular region (Fig. 5i) but not in other regions of the
repopulated kidney (Compare to DAPI stain Fig. 5j).
Discussion
Stem cells have the potential to be used in cellular therapy to
replace damaged cells within a tissue or to completely replace
a damaged organ [31]. One of the main hurdles we face in
achieving the goal of stem cell derived organs is replicating
the three-dimensional structure. Replicating complex organs
such as lung or kidney will require advanced engineering
combined with stem cell biology. Furthermore, it is important
to produce individual organs that are a match for the patient.
Both of these criteria can be met with new technologies.
Decellularized organs provide the detailed three-dimensional
structure required for building a kidney. Previous studies have
demonstrated that the ECM can be preserved after the removal
of all cells [14]. Bovine or porcine organs are candidates for
acellular substrates as are human organs that are donated but
not suitable for transplant. The tissue matching requirement
can be achieved by using induced pluripotent stem cells
(iPSC). We have made advancements in the understanding
of the cell reprogramming process and in producing clinically
relevant iPSCs but there are still large variations between dif-
ferent iPSC lines and the differentiation protocols will need to
Fig. 3 Proteins expressed in
acellular kidney ECM are
enriched for tissue repair and
regeneration. Network
visualization of GO terms
enriched in the set of proteins
expressed in acellular kidney
ECM. Breakdown of the different
pathways are listed in Table 1.
Pathways that reached statistical
significance are focused on cell
migration, proliferation and ECM
interactions that are involved in
cell and tissue repair. Interactions
were derived from various
databases listed in the index
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be individualized for each patient sample [32–35]. Therefore
differentiation protocols and co-culture systems that include
acellular organs are first being developed using embryonic
stem cells. We demonstrated this recently using lung [10].
Robust protocols designed using ES cells will then be adapted
for patient derived iPSC lines.
The repopulation of an acellular organ or tissue can be done
in vitro, prior to transplantation. As well, acellular organs are
useful for establishing advanced 3-D tissue culture systems for
research on cell migration, adherence and cell-ECM interac-
tions. Organ ECM provides for a natural substrate that is sup-
portive of cell growth. For example, a porcine model for blad-
der was used to demonstrate the ability of the host cells adja-
cent to the acellular graft to migrate into the matrix. This
indicates the ability of the acellular matrix to attract and sup-
port cells during tissue regeneration by providing biological
support as well as mechanical support [36]. Acellular tracheas
have been transplanted into patients. The trachea from an
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allogeneic donor was decellularized and then placed in a sus-
pension of the patient’s cells comprised of mobilized endothe-
lial cells, blood cells and mesenchymal stromal cells.
Interestingly, the recipient cells used to initially repopulate
the trachea were replaced by granulation tissue at 6 months
post transplantation and further remodeling resulted in proper
reconstitution with new healthy, ciliated respiratory epithelial
cells. Although the initial cells used to repopulate the trachea
prior to transplant were completely replaced, they conditioned
the acellular matrix by remodeling the ECM which resulted in
long term tissue repair and not scarring [37, 38]. Clinical trials
for bladder reconstruction used acellular matrix from small
intestine and not donor bladders, but they have provided a
proof of principle for reconstructing organs using acellular
matrices [39]. The kidney is a more complex organ therefore
inserting a piece of acellular matrix into the kidney and relying
on cells adjacent to the construct to repopulate it is not feasi-
ble. Even if recipient cells did migrate into the acellular ma-
trix, the likelihood of being able to insert the acellular ECM so
it is aligned properly is highly unlikely considering the large
number of small diameter tubules. Therefore, a whole, intact
acellular kidney would have to be repopulated and cultured
in vitro followed by transplantation. It is possible that partial
repopulation followed by transplantation may be advanta-
geous as the in vivo environment, which includes the blood
supply, should enhance migration, proliferation and differen-
tiation of the cells resulting in a fully functional organ.
Organs respond to damage by initiating a repair program
that involves cell proliferation, migration, remodeling of the
ECM and re-establishment of function. The ECM contains
embedded growth factors that are involved in initiating tissue
regeneration and many of these growth factors are also in-
volved in embryo development and organogenesis, thus there
are strong similarities between organ repair and organogenesis
[40, 41]. The co-opting of some of the embryo development
pathways for tissue repair and the observation that repairing
tubules undergo a de-differentiation step supports the conten-
tion that the ECM could induced the differentiation of nephron
progenitor cells to mature nephron cells but could not allow
for the induction of pluripotent ES cells to mature nephron
cells. The ability of the ECM from adult organs to support
the growth and differentiation of tissue progenitor cells has
been demonstrated in the lung using ES cell-derived endo-
derm [10], with heart using fetal derived cardiomyocytes
[14] and with the kidney using early post natal renal epithelial
cells [1]. The ability of adult ECM to support embryonic, fetal
or early post natal cells is due to the ECM’s involvement in
adult tissue repair and regeneration and the fact that many of
the growth factors used during organogenesis are also used for
tissue repair and are present in the adult organ, including the
ECM. For example SOX9 is upregulated after acute injury in
adult kidneys and inactivation studies in the adult kidney prior
to injury demonstrated it is essential for tissue repair [42].
SOX9 is also present during kidney organogenesis and is
expressed in the ureteric tip, the ureter mesenchyme and in
the S-shaped body [43]. PAX2 shows a similar pattern. It is
expressed at the intermediate mesoderm stage of renal devel-
opment but reappears during renal repair after kidney
ischemia-reperfusion [44, 45].
Organogenesis occurs through growth and remodeling of
the organ, which in part is controlled by MMPs and TIMPs.
The ECM is a reservoir of MMPs and TIMPs and during
kidney development growth factors produced by the meta-
nephric mesenchyme work in tandem with the ECM to regu-
late the expression of MMPs and TIMPs [46]. During kidney
repair MMPs and TIMPs are important for remodeling the
ECM and establishing normal tissue architecture and thus re-
ducing fibrosis and scaring. Other ECM components, such as
Fig. 4 The acellular kidneymatrix can influence the differentiation of ES
cells to mesoderm only, but mature kidney cells can be obtained when
metanephric mesenchyme are used to repopulate the acellular matrix.
When cells were grown for 4–10 days on gelatin coated culture plates
in the absence of the ECM, spontaneous differentiation occurred resulting
in endoderm cells (A) SOX17+ and (B) HNF3β+, and mesoderm (C)
BRY+ cells. Kideny specific proteins (D) Cytokeratin (E) ß-Catenin were
present but the kidney progenitor marker PAX2 and the mature kidney
marker KSP were negative on the gelatin grown cells. (F) OCT4+ cells
indicate many of the cells did not undergo differentiation. In contrast, ES
cells grown on adult kidney ECM showed evidence of directed
differentiation of the ES cells as evidenced by only mesoderm
derivatives being present, specifically kidney precursor markers (Gi) ß-
Catenin (Gii: DAPI) and (H) PAX2. (Ii) Endoderm specific protein
SOX17 was negative. (Iii) KSP was negative (Iiii: DAPI). ES cells
were differentiated in specialized medium to obtain BRY+ mesoderm.
BRY expression in media conditions supplemented with Activin A,
BMP-4 and FGF2 in varying concentrations and combinations were
determined by IF. The total number of cells and the number of BRY
positive cells were scored by counting three random fields per well
(n = 4 wells). (Ji, ii) the relative efficiency of mesoderm production
was 80% + using our optimal protocol: Serum Free Medium (SFM):
DMEM/F12 + 0.5% serum replacement containing Activin A 30 ng/ml
for 2 days resulted in 80% BRY+ cells. (Jiii) RT-PCR confirmed
commitment to mesoderm cell lineage and its derivatives as shown by
expression of Gsc, Eomes and CD56. Mesp1, a marker of mesoderm
regionalization was negative indicating the cells are at an early
mesoderm stage. ß-actin (load control). (K) ES cells were first
differentiated to BRY+ mesoderm then differentiated to intermediate
mesoderm (PAX2+). Different conditions were tested to optimize cell
survival and differentiation. (Ki,ii) Activin A 30 ng/mL + RA 100 nM
in minimal medium (RPMI/0.5% SR) which minimizes exposure of the
cells to unknown proteins, resulted in some PAX2+ cells but high cell
death. (Kiii,iv) Changes in serum and growth factor combinations lead to
a high frequency of PAX2+ cells and high cell survival using
DMEM/high glucose, 4% FBS, 10 μM Y-27632 and 30 ng/ml Activin
A, 100 nmRA. In order to obtainMM SIX2+ cells (L) PAX2+ cells were
grown in varying combinations and concentrations of FGF2 with or
without BMP-7. All conditions showed SIX2 expression, however,
none yielded significantly more SIX2 than (Li) FGF2 at 0.1 ng/ml or
(Lii) FGF2 at 0.1 ng/ml + BMP-7 at 5 ng/ml. As a comparision (Liii)
increasing BMP7 to 25 ng/ml resulted in less SIX2+ cells. (M) PCR
confirmed ES cell derived SIX2+ MM cells expressed other
metanephric mesenchyme specific genes: 1) ß-actin (load control) 2)
Pax2 3) blank well 4) Wt1 5) Cited1 6) Emx2 7) Hoxd11 8) Hoxb7 9)
Sall1 10) Sall4 11) ß-actin (load control) 12) Wt1 13) Cited1 14) Eya1
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Glycosaminoglycan hyaluronan (HA), has a role in regulating
branching morphogenesis during kidney organogenesis by
enhancing the interaction of HA–and it receptor CD44 at the
tips of the new branches as well as promoting cell survival,
proliferation and migration [47]. HA and CD44 have these
same roles in tissue regeneration after renal ischemia-
reperfusion injury. The action of HA is regulated by its mo-
lecular weight with small molecules stimulating inflammation
while larger molecules stimulate cell proliferation and migra-
tion [48]. Although the role of a specific set of proteins, such
as the MMPs, maybe different in organogenesis versus regen-
eration, the fact that they are present and used in both
functions provides a rationale for our observation that adult
ECM can support fetal stage cells. Furthermore, evidence
from the trachea and bladder studies suggests the new cells
can remodel the ECM and create a more appropriate environ-
ment for their survival. Evidence from our lung study also
suggests that the ECM initiates and supports differentiation
but the cells remodel the ECM in a similar manner that occurs
during organogenesis [10].
Interestingly when the mesoderm and IM differentia-
tion protocols were applied to undifferentiated ES cells
grown directly on the ECM, the ES cells did not differ-
entiate and the cells died. This is most likely the result
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of competing or conflicting signals from the ECM and
the additional exogenous factors. We then sought to
determine if ES cells pre-differentiated on gelatin coated
plates to mesoderm or intermediate mesoderm could
continue to differentiate once transferred to acellular
kidney substrates. Although it is possible that mesoderm
or intermediate mesoderm may have differentiated in
response to signals from the acellular kidney we were
unable to test this because cells at these stages could
not be successfully dissociated. E11.5 kidney MM cells
can survive disassociation so we hypothesized that the
differentiation of the ES cells to a similar kidney devel-
opmental stage would allow us to obtain cells that could
be transferred to the acellular kidney. Co-culturing the
ES cell-derived MM cells with acellular kidneys
allowed us to assess the potential of these cells to be-
come identifiable kidney structures. Our data demon-
strated that the adult ECM was compatible with ES
cell-derived MM cells and that this population of cells
was capable of contributing to tubules and podocytes
when co-cultured with acellular kidney ECM. This ob-
servation was expected as the ECM plays an important
role in inducing the de-differentiat ion and re-
differentiation of kidney cells during the natural repair
process [49]. Furthermore, the MM stage kidney cells
have an intrinsic ability to differentiate and undergo
branching morphogenesis in vitro [26]. So it is possible
that the specificity we observed was due to the ECM
supporting cell adherence and survival in a location
specific manner as the mature kidney cells emerged
from the MM.
In this report we present experiments that delineated
a strategy for testing potential therapeutic cells on a 3D
substrate with the long-term prospect of building a
whole bio-artificial organ for transplantation. The data
presented here indicates that the acellular kidney provid-
ed regionalized factors that are highly instructive,
resulting in organized kidney structures within the acel-
lular kidney. The ability to test cells in a three-
dimensional culture provided an intermediate step be-
tween standard cultures and animal models reducing
the cost of cell therapy development. We observed that
combining acellular kidneys with a multi-potential pop-
ulation of kidney cells resulted in organized kidney
morphology. Therefore the presence of regionalized
ECM signals greatly reduced the problem of having to
transplant many different mature kidney cell types dur-
ing the repopulation process. The bioactive role of the
ECM makes whole organ manufacturing more realistic.
3D, Three dimensional; ECM, Extra Cellular Matrix; ES
cell, Embryonic stem cell; H2K,major histocompatibility loci;
IM, In te rmedia te Mesoderm; MM, Metanephr ic
Mesenchyme; SCM, Serum Containing Medium; SFM,
Serum Free Medium.
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Fig. 5 ES cell derived MM cells grown on decellularized kidney
matrices can differentiate to kidney progenitor and mature cells and
develop tubule morphology. In order to determine if kidney progenitor
cells can survive being cultured on acellular kidney matrix, embryonic
day 12.5 mouse renal cells were used as a positive control. (Ai) After
10 days of culture under the same conditions as the ES cell-derived MM
cells, the cell-ECM complexes were fixed and stained for DAPI to
highlight the nuclei. The ECM is visible due to autofluorescence
(green). Most of the ECM was repopulated and cell survival was high.
(Aii) The repopulation frequency of the acellular kidney sections using
ES cell derived MM cells ranged from 10 to 50%. The cell-matrix
construct was stained for the ECM protein Vimentin and the nuclei
stain DAPI to highlight cell distribution within the ECM. (B) We
observed areas of densely populated cells with highly organized tubule
structures adjacent to non-cellular areas indicating cell distribution was
uneven across the matrix during repopulation. Staining with Collagen
type IV indicated the Collagen content was higher in the cellularized
area indicating the cells deposit ECM proteins. (C) During kidney
development PAX2 appears in intermediate mesoderm and condensing
mesenchyme. We observed PAX2+ nuclei in cells found in the cortex
region of the decelluarized kidney (Ci-DAPI, Cii-PAX2). (D) ß-Catenin
is expressed during the transition from metanephric mesenchyme to the
pretubular stage. ß-Catenin positive cells identify cells differentiating into
defined tubule structures. (E) Cytokeratin staining of normal mouse
kidney outlines tubule structures. (Fi-iii) Cytokeratin positive cells
defining tubule structures were apparent when the ES cell derived MM
cells were grown on the ECM and demonstrated a strong similarity in
morphology to normal mouse tubules. (Fiv) Low magnification view of
Cytokeratin staining demonstrated that the nascent tubules are found
throughout the repopulated ECM. (G) KSP, a marker for tubule cells
showed similar results to the Cytokeratin staining and was comparable
to (H) the staining of a normalmouse kidney. (I)WT1 is expressed during
kidney development in the nuclei of cells during renal vesicle formation,
specifically in the prepodocytes during the S-shaped body stage.
Expression continues up to mature podocytes. Importantly, WT-1
expression was localized only to the cells that had attached to the
glomeruli ECM, indicating that the acellular ECM has regional
specificity. Compare WT-1 specific staining in (I-arrow) to total cells in
(J-arrowhead) that are DAPI stained
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